
Actus AFSSI Edito / Tribune Actus Membres Actus sectorielle Actus Partenaires Emploi
Oroxcell – [MN3D] In vitro topical genotoxicity assessment : New assay available
After 3 years of intensive research in collaboration with Nestlé Skin Health (Galderma), the Oroxcell team succeeded in developing a Cytokinesis-Block Micronucleus Assay using Episkin LM™ Reconstructed Human Epidermis (MN3D assay). During the proof of concept testing the method achieved an excellent prediction accuracy of 80% with a set of substances containing progenotoxins known [...]








